The Prophylactic Role of Lipoic Acid as an Antioxidant on the Oxidative Status and Histological Structure of Ovaries and Oviducts in Mesterolone Treated Rabbits
DOI:
https://doi.org/10.61841/fh0zqc85Keywords:
Anabolic Androgenic Steroids (AAS),, Mesterolone,, Alpha Lipoic Acid (ALA),, Protein Carbonyl Contents (PCC),, Malondialdehyde (MDA),, Nuclear Factor Erythroid-2, Related Factor-2 (Nrf2).Abstract
Background: We investigated the effect of α-lipoic acid (ALA) on the administration of anabolic androgenic steroids (AAS) into the rabbit ovary. Changes in the levels of malondialdehyde (MDA) in tissues, the final product of lipid peroxidation, carbonyl protein content (PCC) are usually used as a marker of protein oxidation, regulation of Nrf2 as a sensor of oxidative stress, and histopathological data of the ovaries and oviduct were scored and compared among groups. Materials and methods: Twenty female rabbits were divided into four groups(n = 5 in each group). The control was performed in group (CTRL); in group (Mest) AAS (Mesterolone) received an oral dose of 0.06 mg / kg. Group (ALA) was treated with 50 mg/kg of the alpha lipoic acid and The combined group (Mest + ALA) received both Mesterolone and ALA orally every day for 60 days. After the end of experiment, animals were killed, and samples of ovaries and oviduct tissue from both testes were taken for RNA isolation, biochemical analysis and histological studies. Results: The rates of ovarian tissue damage in different groups were significantly different, and it was found that the MDA levels in the ovarian tissues in the (Mest) group were significantly higher than in the (CTRL) and (ALA) groups (P <0.05). PCC levels in the (Mest) group were significantly higher than in the (CTRL) and (ALA) groups, Nrf2 expression was higher compared to the (CTRL) and (ALA) groups (P <0.05). Conclusion: These results suggest that ALA pretreatment has a positive effect but does not prevent the adverse effects of AAS on the ovaries.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
